Eli Lilly (LLY) Stock: $358 Price Target And Outperform Rating

By Amit Chowdhry ● May 8, 2022
  • The shares of Eli Lilly (NYSE: LLY) have received a $358 price target from BMO Capital. These are the details.

The shares of Eli Lilly (NYSE: LLY) have received a $358 price target from BMO Capital. And BMO Capital analyst Evan David Seigerman increased the price target on Eli Lilly from $330 while maintaining an “Outperform” rating on the shares.

Seigerman adjusted the rating following the company’s first-quarter results. For the first quarter, Seigerman reported a Q1 EPS of $2.62 – which was $0.49 better than the analyst estimates of $2.13. And the revenue for the quarter was $7.81 billion compared to the consensus estimate of $6.68 billion.

In terms of guidance, Eli Lilly expects an FY2022 EPS of $8.15-$8.30, compared to the consensus of $8.19. And the company expects revenue to be between $28.8 billion and $29.3 billion compared to the consensus of $26.8 billion.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.